Bahador Reza, Taheriazam Afshin, Mirghasemi Alireza, Torkaman Ali, Shakeri Mohammadreza, Yahaghi Emad, Goudarzi Peyman Karimi
Department of Orthopaedic and Trauma Surgery, Birjand University of Medical Sciences, Birjand, Iran.
Department of Orthopedics Surgery, Tehran Medical Sciences Branch, Islamic Azad University, Tehran, Iran.
Tumour Biol. 2016 Mar;37(3):3091-5. doi: 10.1007/s13277-015-4140-5. Epub 2015 Oct 1.
Osteosarcoma is the most common type of bone cancer in children and adolescents. MicroRNAs (miRNAs) play important roles in the development, differentiation, and function of different cell types and in the pathogenesis of various human diseases. miRNAs are differentially expressed in normal and cancer cells. The investigation of miRNA expression between healthy subjects and patients with osteosarcoma is crucial for future clinical trials. In this study, the expression levels of miRNAs were detected by qRT-PCR. Correlation between expression levels of tow miRNAs and different clinicopathological characteristics were analyzed using the χ (2) test. Survival rate was detected using the log-rank test and Kaplan-Meier method. qRT-PCR was shown that expression levels of miR-29b and miR-422a were strongly decreased in osteosarcoma bone tissue compared with noncancerous bone tissues. Our result indicated that the low expression levels of miR-29b and miR-422a showed strong correlation with large tumor size (P = 0.20; 0.029), advanced TNM stage (P = 0.001; 0.012), distant metastasis (P = 0.008; 0.019), and grade of tumor (P = 0.009; 0.016). Kaplan-Meier survival analysis showed that the low expressions of miR-29b/miR-422a were correlated with shorter time overall survival (log-rank test, P = 0.009; P = 0.013). Moreover, multivariate Cox proportional hazards model indicated that miR-29b and miR-422a (P = 0.024; P = 0.016) were independent prognostic markers of overall survival of patients. Our result indicated that downregulation of miR-29b and miR-422a may be linked to the prediction of poor prognosis, indicating that miR-29b and miR-422a may be a valuable prognostic marker for osteosarcoma patients.
骨肉瘤是儿童和青少年中最常见的骨癌类型。微小RNA(miRNA)在不同细胞类型的发育、分化和功能以及各种人类疾病的发病机制中发挥着重要作用。miRNA在正常细胞和癌细胞中差异表达。研究健康受试者与骨肉瘤患者之间的miRNA表达对于未来的临床试验至关重要。在本研究中,通过qRT-PCR检测miRNA的表达水平。使用χ²检验分析两种miRNA的表达水平与不同临床病理特征之间的相关性。使用对数秩检验和Kaplan-Meier方法检测生存率。qRT-PCR结果显示,与非癌性骨组织相比,骨肉瘤骨组织中miR-29b和miR-422a的表达水平显著降低。我们的结果表明,miR-29b和miR-422a的低表达水平与肿瘤体积大(P = 0.20;0.029)、TNM分期晚期(P = 0.001;0.012)、远处转移(P = 0.008;0.019)和肿瘤分级(P = 0.009;0.016)密切相关。Kaplan-Meier生存分析表明,miR-29b/miR-422a的低表达与总生存时间缩短相关(对数秩检验,P = 0.009;P = 0.013)。此外,多变量Cox比例风险模型表明,miR-29b和miR-422a(P = 0.024;P = 0.016)是患者总生存的独立预后标志物。我们的结果表明,miR-29b和miR-422a的下调可能与预后不良的预测有关,表明miR-29b和miR-422a可能是骨肉瘤患者有价值的预后标志物。